Blend Therapeutics Appoints Drew Fromkin as President and Chief Executive Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. RH
4. CPRT
5. SPY
6. SEDG
7. PMTS
8. TENB
9. ACVA
10. TLT

Go back to Blend Therapeutics Appoints Drew Fromkin as President and Chief Executive Officer
CLINICAL DATA (NASDAQ: CLDA) Delayed: 30.95 --0 (-0%)
Previous Close $30.95    52 Week High $34.95 
Open $13.36    52 Week Low $10.87 
Day High $30.95    P/E N/A 
Day Low $30.95    EPS $-2.93 
Volume 98,576